Can adding chemo after radiation help older adults with rectal cancer avoid surgery?

NCT ID NCT07118800

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This phase 3 trial is testing whether adding a three-month course of FOLFOX4s chemotherapy after short-course radiotherapy improves outcomes compared to radiotherapy alone in adults aged 75 and older with locally advanced rectal cancer. The study aims to see if the combination can shrink tumors enough to avoid major surgery. Participants are randomly assigned to receive either short-course radiation alone or radiation followed by chemotherapy, with close monitoring for tumor response.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
FOLFOX4s chemotherapy (oxaliplatin, folinic acid, fluorouracil) after short-course radiotherapy
What this could lead to
If successful, this approach could offer a more effective, less invasive treatment option for elderly patients with rectal cancer, potentially avoiding surgery.
What could go wrong
Adding chemotherapy after radiation may increase side effects in older adults. The trial is still testing whether the combination is truly better than radiation alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.